Interstitial lung changes and persistent COVID-19 in a patient with follicular lymphoma: A case report.

Yomota, Makiko; Tanaka, Masaru; Kobayashi, Takayuki; Kitano, Masatake; Ikeda, Saori; Kanemasa, Yusuke; Yanagawa, Noriyo; Hosomi, Yukio.

Afiliação

Yomota M; Department of Respiratory Medicine Tokyo Metropolitan Komagome Hospital Tokyo Japan.
Tanaka M; Department of Infectious Diseases Tokyo Metropolitan Komagome Hospital Tokyo Japan.
Kobayashi T; Department of Respiratory Medicine Tokyo Metropolitan Komagome Hospital Tokyo Japan.
Kitano M; Department of Respiratory Medicine Tokyo Metropolitan Komagome Hospital Tokyo Japan.
Ikeda S; Department of Respiratory Medicine Tokyo Metropolitan Komagome Hospital Tokyo Japan.
Kanemasa Y; Department of Oncology Tokyo Metropolitan Komagome Hospital Tokyo Japan.
Yanagawa N; Department of Radiology Tokyo Metropolitan Komagome Hospital Tokyo Japan.
Hosomi Y; Department of Respiratory Medicine Tokyo Metropolitan Komagome Hospital Tokyo Japan.

Respirol Case Rep ; 12(2): e01298, 2024 Feb.

Article em En | MEDLINE | ID: mdl-38379821

ABSTRACT

We herein report a case of interstitial lung changes in a patient with prolonged coronavirus disease 2019 (COVID-19) with follicular lymphoma receiving rituximab and bendamustine who recovered after treatment with a combination therapy consisting of corticosteroids and immunosuppressive agents. There is currently no treatment strategy for prolonged pneumonitis following COVID-19, which can be life-threatening for immunocompromised patients. Thus, further investigation is warranted.

Palavras-chave

COVID19; lymphoma; pneumonitis; tacrolimus

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article